Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...
BOSTON, May 23, 2025--(BUSINESS WIRE)--Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced that it has expanded its immunohistochemistry (IHC) test ...
IRVING, Texas, May 12, 2025 /PRNewswire/ -- Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer, performs MET Immunohistochemistry (IHC) testing as ...
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project HER2 status was evaluated using ...
PALO ALTO, Calif. - Guardant Health, Inc. (NASDAQ: GH), a precision oncology company valued at approximately $5 billion, has introduced a complete suite of immunohistochemistry (IHC) testing for key ...
The external assessment group (EAG) did a systematic review to identify evidence on the clinical effectiveness and diagnostic accuracy of IHC- and MSI-based testing strategies for detecting Lynch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results